{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:10:54Z","timestamp":1772118654140,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Light chain amyloidosis is a rare disease caused by clonal plasma cells in the bone marrow generating an excessive amount of immunoglobulin light chains. These chains misfold and produce insoluble fibrils that deposit in various organs, including the heart, kidneys, liver, nervous system, and digestive tract. Life expectancy and symptoms during the course of the disease vary depending on which and how many organs are affected. Targeted plasma cell therapy has significantly advanced the clinical management of amyloidosis, with ongoing progress. However, current clinical studies are investigating innovative targets, drug combinations and treatment strategies to improve therapeutic outcomes by minimizing adverse effects and refining patient prognosis in these challenging hematological conditions. In this paper, we review the state of the art regarding the use of anti\u2010amyloid antibodies, as a revolutionary and innovative approach in the current scenario of amyloid treatment.<\/jats:p>","DOI":"10.1002\/hon.3270","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T03:35:10Z","timestamp":1712633710000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel monoclonal antibodies: A really specific therapy for light chain amyloidosis"],"prefix":"10.1002","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-8875","authenticated-orcid":false,"given":"Maria Livia","family":"Del Giudice","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Hematology University of Pisa  Pisa Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7899-5966","authenticated-orcid":false,"given":"Sara","family":"Galimberti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Hematology University of Pisa  Pisa Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Buda","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Hematology University of Pisa  Pisa Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023\u2010022\u201002414\u20106"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016402"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102016\u201011\u2010751628"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102011\u201011\u2010390930"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028631"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020005436"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030484"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102011\u201001\u2010330738"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000846528.55550.9c"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000846484.91738.d2"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12973"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1767566"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201012\u2010687749"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.23693"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408\u2010021\u201000529\u2010w"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7614"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375\u2010018\u20100060\u2010x"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102016\u201001\u2010629790"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052686"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2016.1205974"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.6530"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102014\u201004\u2010570010"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022019406"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.029"},{"key":"e_1_2_9_27_1","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT03168906?term=NCT03168906&rank=1#study\u2010planAccessed on 4 December 2023."},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V130.Suppl_1.5437.5437"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102018\u201007\u2010865857"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010174703"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi0616605"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002\u20109440(10)64639\u20101"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2017.1292900"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2019.1584892"},{"key":"e_1_2_9_35_1","article-title":"PW065 long term follow\u2010up of patients with AL amyloidosis treated on a phase 1 study of anti\u2010amyloid monoclonal antibody CAEL\u2010101","author":"Bhutani D","year":"2020","journal-title":"International Symposium on Amyloidosis (ISA)"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010162597"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102023\u2010186515"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102021\u2010152488"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.102764"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102021\u2010151908"},{"issue":"4","key":"e_1_2_9_41_1","first-page":"699","article-title":"Kinetic studies with iodine\u2010123\u2010labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value","volume":"39","author":"Jager PL","year":"1998","journal-title":"J Nucl Med"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040629"},{"key":"e_1_2_9_43_1","unstructured":"WallJ KleinLM SelvarajahS et\u00a0al.OP037 Preclinical Characterization of AT\u201002 a Pan\u2010Amyloid\u2010Binding Immunoglobulin\u2010Peptide Fusion Protein Capable of Inducing Enhanced Phagocytosis of Amyloid. Accessed on 7 December 2023.https:\/\/www.isaheidelberg2022.org\/wp\u2010content\/uploads\/sites\/24\/20220902_ISA22_Abstract\u2010Book_final.pdf"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066181"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09494"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan3128"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12872\u2010021\u201002407\u20106"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.3270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T14:11:39Z","timestamp":1719583899000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.3270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1002\/hon.3270"],"URL":"https:\/\/doi.org\/10.1002\/hon.3270","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/HON.3270\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.3270\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.3270\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/HON.3270\/v1\/decision1","asserted-by":"object"}]},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"value":"0278-0232","type":"print"},{"value":"1099-1069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"2023-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e3270"}}